Home › Autoimmune Diseases › Minnesota › Minneapolis
Autoimmune Diseases clinical trials in Minneapolis, MN
4 studies for Autoimmune Diseases are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
RecruitingPhase 2Healthy volunteers welcome
- National Marrow Donor Program, Minneapolis
Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
RecruitingPhase 1
- University of Minnesota Delaware Clinical Research Unit, Minneapolis
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecruitingPhase 1/2
- University of Minnesota, Minneapolis
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
- University of Minnesota Medical School, Minneapolis
About Autoimmune Diseases
Autoimmune diseases are where your immune system attacks healthy cells in your body by mistake. Learn about the symptoms, tests, and treatments.
More about Autoimmune Diseases on MedlinePlus
Autoimmune Diseases trials in other cities
- Houston, TX21 studies
- Washington, DC19 studies
- New York City, NY19 studies
- Philadelphia, PA17 studies
- Durham, NC15 studies
- Boston, MA13 studies
- Chicago, IL13 studies
- Los Angeles, CA12 studies
- Atlanta, GA9 studies
- Dallas, TX9 studies
- Miami, FL8 studies
- Milwaukee, WI8 studies
Other studies in Minneapolis
- Non-Small Cell Lung Cancer29 studies
- Breast Cancer23 studies
- Ovarian Cancer23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Cancer (all types)21 studies
- Endometrial Cancer20 studies
- Colorectal Cancer20 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Parkinson's Disease17 studies
- Coronary Artery Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.